Practice Alerts

On September 16, 2014, Governor Cuomo signed a bill that would go in to effect on December 15, 2014, allowing physicians and nurse practitioners to authorize registered nurses, when appropriate, to administer the hepatitis C test to a patient without the need for a patien

The purpose of this advisory is to call your attention to important guidelines for the safe use of insulin pens. Recently, two facilities in New York State discovered that insulin pens, designed for use on a single patient, had been used or might have been used for multiple patients.

The anemia drug peginesatide (Omontys, Affymax and Takeda Pharmaceuticals) has been voluntarily recalled by the manufacturers, after reports of anaphylaxis leading to 3 deaths, the US Food and Drug Administration (FDA) announced today.